⌘K

Login Start Free

Home/Filings/4/0001144204-17-037574

4//SEC Filing

Maza Elliot M 4

Accession 0001144204-17-037574

CIK 0001208261other

View on SEC.gov Company Profile

Filed

Jul 19, 8:00 PM ET

Accepted

Jul 20, 8:52 PM ET

Size

5.8 KB

Accession

0001144204-17-037574

Insider Transaction Report

Form 4

Period: 2017-07-18

IMMUNE PHARMACEUTICALS INCIMNP

Director

Transactions

Award
Stock Option
2017-07-18+100,000→ 162,000 total
Exercise: $2.69From: 2017-07-18Exp: 2027-07-18→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]The option to purchase up to 100,000 shares of the Issuer's common stock shall vest as follows: (i) the option to purchase up to 50,000 shares of common stock vest on the date of grant and (ii) the balance of the option, or the option to purchase up to 50,000 shares of common stock shall vest quarterly over a two year period, subject to shareholder approval.

Documents

1 file

4
v471199_4.xmlPrimary
FORM 4

Issuer

IMMUNE PHARMACEUTICALS INC

CIK 0001208261

Entity typeother

Related Parties

1

filerCIK 0001270365

Filing Metadata

Form type: 4
Filed: Jul 19, 8:00 PM ET
Accepted: Jul 20, 8:52 PM ET
Size: 5.8 KB

View on SEC.gov